Cytochromes P450 catalyze oxygenation reactions via interactions with their redox partners. However, other proteins, particularly other P450s, also have been shown to form complexes that modulate P450 function. Previous studies showed that CYP1A2 and CYP2B4 form a complex when reconstituted into phospholipid vesicles; however, details of the interactions among the P450s and NADPH-cytochrome P450 reductase have not been fully characterized. The goal of this study was to examine P450 complex formation in living cells, using bioluminescence resonance energy transfer (BRET). Various pairs of P450 and POR constructs were tagged with either GFP or Renilla luciferase, and transfected into HEK-293T cells. Complexes were demonstrated by measuring energy transfer between the tags, and disruption of the complex was verified by co-transfection with unlabeled P450-system proteins.
DMD # 78642

Introduction
The cytochromes P450 (P450s) are a superfamily of hemoproteins responsible for the metabolism of a majority of prescribed drugs (Guengerich, 2006; Lynch and Price, 2007) . In the endoplasmic reticulum (ER), P450s require physical interaction with their redox partners NADPH-cytochrome P450 reductase (POR) and cytochrome b 5 to accept the electrons required for activity. P450s substantially outnumber POR in the ER of most tissues (Peterson, et al., 1976; , and the ER contains numerous P450s (Zanger and Schwab, 2013) , each requiring physical interaction with POR to metabolize substrates. This raises questions regarding how P450 system proteins are organized in order to facilitate catalysis effectively.
Early studies suggested that P450 enzymes would compete for available POR as predicted by mass action (West and Lu, 1972; Miwa, et al., 1979) ; however, in many cases simple competition could not fully explain the observed effect of one P450 on another (Kaminsky and Guengerich, 1985; Dutton, et al., 1987; Cawley, et al., 1995; Backes, et al., 1998) .
Direct evidence that one P450 affects the function of another P450 was shown using mixed reconstituted systems containing CYP1A2, CYP2B4, and subsaturating POR. Under these conditions, CYP2B4 activities were inhibited, whereas CYP1A2 activities were stimulated (Backes, et al., 1998) . These results could not be explained by simple competition between the P450s for POR, and led to the hypothesis that CYP1A2 and CYP2B4 formed a complex that caused the high affinity binding of POR to the CYP1A2 moiety (Backes, et al., 1998; Kelley, et al., 2005; Kelley, et al., 2006) . These functional changes required both proteins to be in the same vesicles -when the different P450s were reconstituted into separate vesicles, neither inhibition of CYP2B4 nor activation of CYP1A2 activities were observed. Additionally, physical CYP2B4•CYP1A2 complexes were detected in mixed reconstituted systems by crosslinking/immunoprecipitation (Reed, et al., 2010) and in detergent solutions by FRET using forms of the enzymes that were labeled with fluorescent probes (Davydov, et al., 2001) .
Evidence for interactions between these proteins also was observed in microsomal preparations DMD # 78642 (Cawley, et al., 2001) . Taken together, the data support the existence of a POR•CYP1A2•CYP2B4 ternary complex at subsaturating POR.
Interactions between P450s are not unique to the CYP1A2/CYP2B4 system. Heteromeric complexes have been reported either by demonstrating physical complexes between the P450s (e.g. human CYP2C9/CYP3A4 and rat CYP1A1/CYP3A2) (Subramanian, et al., 2010; Alston, et al., 1991) or by showing that their presence in mixed systems affects P450 function (CYP1A2/CYP2E1, CYP2C9/CYP2D6, CYP3A4/CYP2E1 and CYP2C9/CYP3A4) (Kelley, et al., 2006; Subramanian, et al., 2009; Subramanian, et al., 2010; Davydov, et al., 2015) . Homomeric complexes have also been shown with CYP2C8, CYP2E1, CYP1A2 and CYP3A4 (Hu, et al., 2010; Jamakhandi, et al., 2007; Reed, et al., 2012; Fernando, et al., 2008; Davydov, et al., 2013; Davydov, et al., 2015) .
The goal of this study was to demonstrate that POR, CYP1A2, and CYP2B4 exist in cellular systems as a stable ternary complex. This was accomplished by expressing these proteins in HEK-293T cells and detecting the presence of complexes using bioluminescence resonance energy transfer (BRET). The results show that CYP1A2 and CYP2B4 form a stable complex in membranes, and that POR preferentially binds to the CYP1A2 moiety of the CYP1A2•CYP2B4 complex resulting in CYP-specific alterations in catalytic activities.
Furthermore, CYP1A2 forms homomeric complexes that are disrupted by the presence of excess POR.
DMD # 78642
Materials and Methods
Materials. Dulbecco's Modified Eagle's Medium (DMEM), phosphate buffered saline (PBS), fetal bovine serum (FBS), and Lipofectamine 2000 were purchased from Invitrogen (Eugene, OR). The plasmids used to generate BRET vectors (pGFP 2 -N1, pGFP 2 -N2, pRluc-N2, pRluc-N3) and the pGFP 2 -Rluc vector were obtained from BioSignal Packard (Waltham, WA).
GFP 2 is a wild-type green fluorescent protein (GFP) that has been modified by a F64L substitution mutation which results in brighter fluorescence but similar excitation and emission spectra. Human embryonic kidney (HEK)-293T/17 cells were obtained from ATCC (Manassas, VA). Antibiotic-antimycotic solution was purchased from Life Technologies (Carlsbad, CA).
Coelenterazine 400A was purchased from Gold Biotechnology (St. Louis, MO), and coelenterazine h was purchased from Promega (Madison, WI). 7-pentoxyresorufin and 7-ethoxyresorufin were purchased from Anaspec (Fremont, CA), and cytochrome c was obtained from Sigma (St. Louis, MO).
Generation of BRET vectors.
Each of the P450s and POR were wild-type proteins without any modifications to their amino acid sequences. To generate the BRET expression vectors, linear cDNA coding for full-length, wild-type rabbit CYP1A2 (NM_001171121), CYP2B4 (NM_001170859), and POR (NM_001160290) was amplified from existing bacterial expression vectors with PCR using primers to introduce restriction sites that immediately flanked the full length gene, excluding the stop codon. The restriction sites (with the 5' site listed first) were:
EcoRI and BamHI for CYP1A2, NheI and EcoRI for CYP2B4, and EcoRI and HindIII for POR.
These PCR products were then ligated into the empty vectors (pGFP 2 -N1 and pRluc-N2 for the P450s, pGFP 2 -N3 and pRluc-N1 for POR) after each was digested by the indicated pair of restriction enzymes (New England Biolabs, Inc.; Ipswich, MA). The multiple cloning sites of the vectors is upstream of the GFP or Rluc tag. This information is summarized in Supplemental Table 1 . This orientation was chosen to ensure that the heterologous protein tags were less likely to interfere with the ability of the proteins' N-terminal membrane-binding regions to insert This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on December 12, 2017 as DOI: 10.1124 at ASPET Journals on January 6, 2018 dmd.aspetjournals.org Downloaded from into the ER membrane. Due to the restriction sites used, the BRET vectors code for a 5-20 amino acid sequence between the 3' end of the inserted gene and the start codon for the GFP or Rluc tag. To generate vectors for the expression of untagged, wild-type CYP1A2, CYP2B4, and POR, site-directed mutagenesis was performed to create a stop codon immediately 3' to the main protein sequence. Site-directed mutagenesis was performed using the QuikChange II kit from Agilent Technologies (Santa Clara, CA). All PCR amplification and mutagenesis primers were purchased from Integrated DNA Technologies (Coralville, IA). Insertion of cDNA and mutagenesis were confirmed by sequencing (ACGT; Germantown, MD).
Cell culture and transfection. HEK-293T/17 cells were maintained under a humidified 37°C atmosphere supplemented with 5% CO 2 . Cell growth media consisted of DMEM supplemented with 10% FBS and 1× antibiotic-antimycotic solution (100 units/mL penicillin, 100 μg/mL streptomycin, and 250 ng/mL amphotericin B). Six-well plates were seeded with cells so that they were >90% confluent at the time of transfection the following day.
Transfections were performed using pre-formed complexes of Lipofectamine 2000 with 1-2 μg DNA per well. Empty plasmid (pUC19) was used to ensure all transfections contained the same quantity of DNA.
BRET assays. For BRET assays, cells were first transfected with 1 μg total DNA at different ratios of the GFP and Rluc constructs. The goal for these transfections was to generate a series of cells expressing the same total protein at a range of GFP:Rluc ratios to ensure that the BRET complexes were specific and not due to changes in protein concentration. If this transfection strategy yielded approximately the same total protein expression across all conditions, the results were considered valid. In most cases, however, one or two additional trials were necessary to achieve constant levels of protein expression. After allowing at least 24 hours for protein expression, cells were checked using fluorescence microscopy to ensure efficient expression of the GFP fusion proteins. Each transfection was performed with the following three controls: a GFP-Rluc fusion protein, the Rluc fusion protein alone, and cells DMD # 78642 transfected with only pUC19. Cells were harvested in 1 ml PBS, centrifuged, and resuspended in 700 μl PBS. For BRET measurements, 100 μl of suspended cells were distributed in quadruplicate into an opaque white 96-well plate. A TriStar LB 941 microplate reader (Berthold Technologies; Bad Wildbad, Germany) was used for BRET measurements. This plate reader was programmed to perform the following actions for each well: inject 100 μl of a 10 μM coelenterazine 400A/PBS solution, shake for 1s to mix, read Rluc emission for 3s at 410 nm, and read GFP emission for 3s at 515 nm. To calculate the BRET ratio, the average GFP and
Rluc emission values from the untransfected control cells were used to zero each individual measurement, then the raw BRET signal was calculated by dividing the GFP signal by the Rluc signal. Finally, the net BRET value was obtained by subtracting the baseline BRET ratio generated by cells expressing Rluc tagged protein alone. Rluc expression was measured in the microplate reader using the fourth quadruplicate of each experimental condition. Coelenterazine h was added to these wells to a final concentration of 5 μM, and unfiltered emission was measured for 1 s. Each sample's GFP and Rluc signals were then normalized to that of the GFP-Rluc fusion protein (which is assumed to have a 1:1 GFP:Rluc expression ratio), so that dividing the normalized GFP value by the normalized Rluc value yielded an approximation of the actual GFP:Rluc expression ratio. lysate was centrifuged at 10,000 x g for 20 minutes to pellet debris. The supernatant was collected and centrifuged at 110,000 x g for 1 hour after which the pellet was resuspended in 500 μl. GFP fluorescence was measured in 1:20 dilutions of each sample to estimate the GFPtagged P450 concentration relative to a previously generated standard curve using western blot densitometry. Four reaction conditions were then prepared based on these data: microsomes containing CYP1A2-GFP alone, CYP2B4-GFP alone, and microsomes containing both CYP1A2-GFP and CYP2B4-GFP. Samples were arranged in quadruplicate in a 96-well clearbottom plate with added substrate (7-ethoxyresorufin or 7-pentoxyresorufin) and incubated for 5 minutes at 37°C in a SpectraMax M5 plate reader. The rates of ethoxyresorufin O-dealkylation (EROD) and 7-pentoxyresorufin O-dealkylation (PROD) were then measured in real time by fluorescence after the reactions were initiated by addition of NADPH. To determine the relative expression of CYP1A2-GFP and CYP2B4-GFP in the co-transfected cells, samples were analyzed using SDS-polyacrylamide gel electrophoresis and western blotting with a GFPspecific antibody along with a purified GFP standard (Vector Laboratories; Burlingame, CA). POR levels were determined by measuring NADPH-dependent reduction of cytochrome c (Sigma). Microsomes and cytochrome c (final concentration 360 μM) in 0.1 mM potassium phosphate buffer (pH 7.25) were incubated in quadruplicate in black, clear-bottom, 96-well plates at 37°C for 5 minutes. Reactions were initiated by the addition of NADPH and reaction progress was monitored by measuring the difference in absorbance between 550 nm and the 541 nm isosbestic point as described (Cawley, et al., 2001; Yasukochi and Masters, 1976) .
Known amounts of purified POR (Marohnic, et al., 2011) were used to create a standard curve for quantification.
Using the measured protein concentrations, and previously-determined K D values between POR and CYP1A2 (Backes, et al., 1998; Reed, et al., 2012) ; and POR and CYP2B4 (Backes, et al., 1998; Brignac-Huber, et al., 2013 ) the expected activities for PROD and EROD were calculated under conditions where the co-transfected systems followed a model allowing for only simple competition using Dynafit 4 (Backes, et al., 1998) . The text files used can be found in Supplemental Figure 
Results
Characterization of the physical complexes among CYP1A2, CYP2B4, and POR. In previous reports, we provided both kinetic and physical evidence that CYP1A2 and CYP2B4 form a heteromeric complex in reconstituted systems (Backes, et al., 1998; Reed, et al., 2010) and microsomes (Cawley, et al., 2001 ). Based on kinetic data, formation of this heteromeric complex causes the selective high affinity association of POR to the CYP1A2 moiety of this complex. The goal of this study was to demonstrate that the POR•CYP1A2•CYP2B4 complex is formed in the endoplasmic reticulum of living cells after recombinant expression, and more specifically, to identify the specific physical protein-protein interactions involved. This was accomplished by tagging CYP1A2, CYP2B4 and POR with either Rluc or GFP, after transient transfection into HEK-293T/17 cells. Complex formation was then measured using BRET.
The first step was to show that BRET can be used to detect CYP1A2:CYP2B4 complexes in HEK-293T/17 cells. This was done by transfecting CYP1A2-GFP and CYP2B4-Rluc constructs at various ratios so that total protein expression remained approximately constant. Under these conditions, a specific protein-protein interaction between the GFP-and Rluc-labeled proteins will yield a saturation curve as the relative level of GFP expression increases (James, et al., 2006) . The asymptote to which these curves trend at high GFP:Rluc (BRET max ) represents the condition in which every Rluc-tagged protein is maximally surrounded by a GFP-tagged protein. Changes in BRET max can therefore be interpreted as changes in the fraction of interacting BRET pairs. Nonspecific interactions generate a curve that is independent of the expression ratio. Fig. 1A shows that we are able to detect an interaction between CYP1A2 and CYP2B4 using BRET.
If the CYP1A2-CYP2B4 complex is responsible for the previously observed changes in P450 activity (Backes, et al., 1998) , it should be refractory to disruption by POR. To determine if the CYP1A2•CYP2B4 complex was stable, HEK-293T/17 cells were transfected with CYP1A2-GFP and CYP2B4-Rluc both in the presence and absence of co-transfected unlabeled POR. The results (Fig. 1B) show that POR does not interfere with the BRET complex, and is consistent with CYP1A2•CYP2B4 being stable in the presence of POR.
Although these data indicate that the CYP1A2•CYP2B4 complex is stable, they do not conclusively show that POR interacts with the P450s in the CYP1A2•CYP2B4 complex, nor do they show whether there is selective binding of POR to a particular moiety of that complex. Our previous kinetic data support the formation of a CYP1A2•CYP2B4 complex with POR selectively associating with the CYP1A2 moiety (Backes, et al., 1998) . If this is the case, a CYP2B4/POR BRET pair should generate a signal that is disrupted by the addition of unlabeled CYP1A2; however, BRET measured from a CYP1A2/POR BRET pair should not be affected by the addition of unlabeled CYP2B4. In the first experiment (Fig. 2) , a BRET signal was measured in cells transfected with the CYP2B4-GFP/POR-Rluc BRET pair, clearly showing the formation of a specific CYP2B4•POR complex. Co-transfection of unlabeled CYP1A2 caused a sharp decrease in BRET max for this pair. These data demonstrate that CYP1A2 disrupts the CYP2B4•POR interaction, and provides an explanation for the inhibition of CYP2B4 activity in the presence of CYP1A2 (Backes, et al., 1998; Reed, et al., 2010) .
In the converse experiment, the effect of unlabeled CYP2B4 on the interaction between POR-Rluc and CYP1A2-GFP was examined. If POR selectively binds to the CYP1A2 moiety of a POR•CYP1A2•CYP2B4 complex, the addition of unlabeled CYP2B4 would not be expected to disrupt POR•CYP1A2 binding. POR-Rluc and CYP1A2-GFP were transfected into HEK-293T/17 cells, producing a BRET signal consistent with complex formation between the proteins (Fig. 3) . Co-transfection of unlabeled CYP2B4 did not disrupt this complex. Taken proteins. Generally, co-transfection of a second or third P450 system protein leads to lower expression levels of the others. To circumvent this variability, the experimentally obtained activities were compared to those expected if CYP1A2 and CYP2B4 did not form a complex, and simply competed for the available POR. CYP1A2-mediated EROD and CYP2B4-mediated PROD activities were measured using microsomes from cells that were transfected with CYP1A2-GFP, CYP2B4-GFP, or both. When both P450s were co-transfected, CYP2B4-mediated PROD activity was lower (Fig. 4A) , whereas CYP1A2-mediated EROD was greater than that predicted by simple competition between the P450s for limiting POR (Fig. 4B ). These data show that the presence of CYP2B4 enhances CYP1A2-mediated EROD, and the presence of CYP1A2 inhibits CYP2B4-mediated PROD, in a manner consistent with the expected characteristics of the CYP1A2•CYP2B4 complex as determined from the studies with purified, reconstituted systems.
Characterization of homomeric P450 complexes in cellular systems. We previously demonstrated that CYP1A2 exhibits non-Michaelis-Menten, sigmoidal behavior when CYPdependent activities were measured as a function of POR concentration. Furthermore, it was shown that the ability of CYP1A2 to form homomeric complexes was retained in both reconstituted systems and the ER membrane of living cells. Formation of this complex was verified by the disruption of the CYP1A2-Rluc/CYP1A2-GFP BRET pair by the co-transfection of unlabeled CYP1A2 (Reed, et al., 2012) . These results suggested that the CYP1A2•CYP1A2 complex might be related to the sigmoidal kinetic response, and suggested that POR might be capable of disrupting the CYP1A2•CYP1A2 complex. To test this possibility, HEK-293T/17 cells were transfected with CYP1A2-GFP and CYP1A2-Rluc, and BRET measurements yielded the
at ASPET Journals on January 6, 2018 dmd.aspetjournals.org Downloaded from expected saturation curve (Fig.5, blue) . When this BRET pair was co-transfected with unlabeled POR, a curve with a lower BRET max was generated, indicating that POR (at approximately 1:2 POR:CYP1A2 transfection ratio) decreased the proportion of multimeric CYP1A2 (Fig. 5, red) .
These data are consistent with the hypothesis that CYP1A2 can exist in the membrane, at least in part, as a homomeric complex that can be destabilized by the presence of POR. Fig. 6 shows the potential for homomeric complex formation of CYP2B4. Although the curve appears to exhibit saturation, the saturation does not occur at a 1:1 GFP:Rluc ratio as required for specific homomeric complexes (Mercier, et al., 2002) . Furthermore, the CYP2B4-GFP/CYP2B4-Rluc signal is not affected by co-transfection of unlabeled CYP2B4, suggesting either that CYP2B4 does not form a specific homomeric complex or that such a complex is not detectible due to the stringent conditions required to activate the GFP 2 /Rluc BRET pair.
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Discussion
Interactions between P450s not only have been established for several P450s, but in many instances also have been shown to influence monooxygenase function (Reed, et al., 2010; Kelley, et al., 2006; Hazai and Kupfer, 2005; Subramanian, et al., 2009; Subramanian, et al., 2010; Davydov, et al., 2015) . The interaction between CYP1A2 and CYP2B4 is the most studied of these pairs, with kinetic experiments precluding the possibility that the two P450s were competing for POR by a simple mass-action process. In these studies, the apparent affinity of CYP1A2 for POR increased significantly in the presence of CYP2B4 (Backes, et al., 1998) . Similar functional effects were seen in microsomes purified from rabbit liver (Cawley, et al., 2001 ), leading to the hypothesis that CYP1A2 and CYP2B4 exist in a heteromeric complex that affects P450 function. Davydov et al. (Davydov, et al., 2001 ) subsequently published data showing that purified CYP1A2 and CYP2B4, in the presence of detergent Emulgen-913, formed heteromeric complexes using Förster resonance energy transfer. This work also corroborated the finding that POR preferentially bound to CYP1A2 when in the presence of CYP2B4 and substrate 7-ER (Davydov, et al., 2001) . Further work showed that the kinetic behavior of the binary P450 system, containing both CYP1A2 and CYP2B4, reverted to simple competition when the ionic strength of the solution was increased, which is consistent with the disruption of a P450 complex that is stabilized by electrostatic interactions (Kelley, et al., 2005 ). The functional effects were then shown to occur only when CYP1A2 and CYP2B4 were reconstituted in the same lipid vesicles, and the formation of a physical complex between CYP1A2 and CYP2B4 was shown by chemical cross-linking/immunoprecipitation (Reed, et al., 2010 ).
The work presented here more specifically focuses on the physical complexes that exist among POR, CYP1A2 and CYP2B4 in living cells. The results provide strong evidence for the presence of the CYP1A2•CYP2B4 complex in a living system whose interaction with POR strongly favors binding via the CYP1A2 moiety. In the simplest protein complex that describes the results, the dominant active species is a trimer with both POR and CYP2B4 bound to CYP1A2, but not to each other. The studies also showed that the characteristic functional effects of CYP1A2/CYP2B4 systems were retained in living cells, which both solidifies the role of physical complexes in these effects and shows that they exist in natural membranes.
In addition to its heteromeric interactions with POR and CYP2B4, CYP1A2 was shown to form homomeric complexes in a number of systems (Reed, et al., 2012) . Using a kinetic analysis, our laboratory previously demonstrated that some, but not all, CYP1A2-dependent activities produce a sigmoidal response as a function of POR concentration, which becomes more prominent as the CYP1A2 concentration is increased. This response is consistent with the formation of a homomeric CYP1A2-CYP1A2 complex. Interestingly, the sigmoidal response can be converted to hyperbolic Michaelis-Menten behavior by increasing the ionic strength of the buffer -again consistent with the formation of a complex that is stabilized by ionic interactions. These kinetic data were corroborated by demonstration of BRET-detectable physical CYP1A2-CYP1A2 complexes, and that it formed specific BRET-detectable homomeric complexes (Reed, et al., 2012) . Here we extend this work and show that these BRET-detectable physical CYP1A2 complexes can be disrupted by the co-transfection of POR. This disruption corroborates earlier work showing that reconstituted CYP1A2 was 20% immobile alone and 11% immobile in the presence of POR when examined using rotational diffusion (Yamada, et al., 1995) . The evidence as a whole points to a system where CYP1A2 forms homomeric multimers that are either unable to associate with POR (Reed and Backes, 2017) , or have a lower specific activity than monomeric CYP1A2. POR appears to be able to induce disruption of these complexes (as was seen in our previous work as reaction rates became proportional to CYP1A2 levels with excess POR). CYP2B4 appears to have a similar effect on the CYP1A2•CYP1A2 complex. As CYP1A2 is a highly inducible P450, this effective deactivation at higher expression levels could act as a mechanism to balance the protein's oxygenase activity and uncoupled production of ROS, an effect similar to that proposed in a recently presented model (Davydov, et al., 2015; Davydov, 2011) . As noted previously, with some substrates, the presence of CYP2B4 actually appears to have increased the activity of CYP1A2. This effect was seen again in microsomes prepared from HEK-293T cells transfected with both P450 enzymes (the same system as the BRET experiments).
Although BRET can definitively show whether two proteins form a complex, it is somewhat limited in that it cannot directly determine the affinities of protein-protein interaction or the size of the supramolecular complexes. The model of a CYP1A2-CYP2B4 dimer interacting as a unit with POR is the simplest explanation for our observations but we cannot rule out larger and/or more complex physical organization of these proteins. Additionally, because energy transfer depends on the orientation of the two chromophores in addition to their proximity, the lack of a strong BRET signal does not absolutely imply the lack of complex formation. R 0 (the distance at which energy transfer efficiency is 50% of the maximum between a BRET pair) for Renilla luciferase and GFP was experimentally determined to be 7.50 ± 0.03 nm (Dacres, et al., 2010) . This distance is similar in scale to that of CYP1A2 as determined by its crystal structure (Sansen, et al., 2007) . Since the protein tags used in this work are appended to the C-terminus of each enzyme, and each enzyme has its orientation restricted by the Nterminal membrane-binding domain, any proteins in physical contact would probably have their BRET pair within the 7.5 nm range. Proteins not in contact would quickly fall out of the range of efficient energy transfer.
GFP-tagged proteins were used as a means to confirm that tagged proteins retained activity, to facilitate the measurement of protein concentration at the time of the experiment, and to allow the direct comparison of both CYP1A2-GFP and CYP2B4-GFP on the same western blot by using a GFP antibody. Transfection with equal amounts of cDNA for each tagged P450 led to more expression of CYP2B4-GFP than CYP1A2-GFP. CYP1A2-GFP constituted 53% of total GFP-tagged protein expression in the final iteration of the experiment after adjusting the ratio of transfected DNA. was shown to form a homomeric complex that could be disrupted by increasing POR concentrations. Taken together, these results suggest an intricate interplay between the relative concentrations of different P450 systems proteins, their ability to form complexes, and their effect on P450 function. Future studies are required not only to identify the size of these supramolecular complexes, but also to determine how complex formation is affected by their localization into specific membrane regions (Brignac-Huber, et al., 2011; Park, et al., 2014; Brignac-Huber, et al., 2016; Park, et al., 2015) . N1/CYP1A2-GFP, pGFP 2 -N1/CYP2B4-GFP, or both. Microsomes derived from these cells were then incubated in the presence of either 7-pentoxyresorufin or 7-ethoxyresorufin, and the initial rate of resorufin accumulation was determined spectrofluorometrically. The experimentally determined rates were then compared with those predicted for CYP1A2 and CYP2B4 if they behaved as monomers that simply competed for the available POR. Because each group of transfected cells contained different levels of POR, CYP1A2, and CYP2B4, the predicted rates were determined using Dynafit 4, based on the model described in Supplemental Figure 1. Consequently, if the P450 enzymes affected each other's function, the experimental data would be expected to deviate from the "predicted" activities. This analysis showed that co-transfection of both P450s led to lower rates of PROD (panel A), and higher rates of EROD (panel B) than predicted by simple competition. Protein concentrations from the CYP1A2 group were 0.048 μM and 0.005 μM for CYP1A2 and POR, respectively. Concentrations for the CYP2B4 group were 0.040 μM and 0.005 μM for CYP2B4 and POR, respectively. Concentrations for the group co-transfected with both CYP1A2 and CYP2B4 were 0.051 μM, 0.045 μM, and 0.005 μM for CYP1A2, CYP2B4 and POR, respectively. The activities represent the mean ± SEM for 4
replicates. Unpaired t-test: *, p < 0.05, ***, p < 0.001 for the difference between the measured and predicted values. Vector information. Vectors for the expression of labeled proteins were generated by ligating full-length cDNA into the empty BRET vectors shown above. The primers used to amplify the DNA of interest included the indicated restriction sites immediately flanking the coding sequence except for CYP1A2-GFP and CYP1A2-Rluc, for which extra thymidine residues were included between the CYP1A2 CDS and the BamHI site to ensure the tag was in frame. The 3' primers did not include a stop codon.
Each tagged construct had DNA between the 3' restriction site and the GFP or Rluc start codon that resulted in the expression of short peptide linker between the protein of interest and its tag.
To generate vectors for the expression of wild type, unlabeled protein, site directed mutagenesis was used to introduce a stop codon to the immediate 3' end of the GFP-tagged protein's CDS, destroying the 3' restriction site. For CYP1A2 TGG was changed to TGA, for CYP2B4 GAA was mutated to TAA, and for POR AAG was replaced with TAG. ) was 0.01μM [11;23] . K as , and K ars are the dissociation constants for substrate binding to CYP1A2, and CPR•CYP1A2, respectively. K bs , and K brs are the dissociation constants for substrate binding to CYP2B4, and CPR•CYP2B4, respectively. The rate constants for product formation by the CPR•CYP1A2•S and CPR•CYP2B4•S are "k ars and k brs , respectively. The values for k ars and k brs for PROD were 0.38/min and 1.25/min, and were determined from the single-transfection systems. The values for k ars and k brs for EROD were 8.67/min and 0.015/min, and were determined from the single-transfection systems. This script is based on the following assumptions: (a) Both CYP1A2 and CYP2B4 behave as functional monomers that compete for limiting CPR. directory ./interaction/output/models [end] 
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